| Literature DB >> 20354143 |
Sandra Pastorino1, Hemamalini Renganathan, Maisel J Caliva, Erin L Filbert, John Opoku-Ansah, Florian J Sulzmaier, Joanna E Gawecka, Guy Werlen, Andrey S Shaw, Joe W Ramos.
Abstract
PEA-15 is a death effector domain-containing phosphoprotein that binds ERK and restricts it to the cytoplasm. PEA-15 also binds to FADD and thereby blocks apoptosis induced by death receptors. Abnormal expression of PEA-15 is associated with type II diabetes and some cancers; however, its physiological function remains unclear. To determine the function of PEA-15 in vivo, we used C57BL/6 mice in which the PEA-15 coding region was deleted. We thereby found that PEA-15 regulates T-cell proliferation. PEA-15-null mice did not have altered thymic or splenic lymphocyte cellularity or differentiation. However, PEA-15 deficient T cells had increased CD3/CD28-induced nuclear translocation of ERK and increased activation of IL-2 transcription and secretion in comparison to control wild-type littermates. Indeed, activation of the T-cell receptor in wild-type mice caused PEA-15 release of ERK. In contrast, overexpression of PEA-15 in Jurkat T cells blocked nuclear translocation of ERK and IL-2 transcription. Finally, PEA-15-null T cells showed increased IL-2 dependent proliferation on stimulation. No differences in T cell susceptibility to apoptosis were found. Thus, PEA-15 is a novel player in T-cell homeostasis. As such this work may have far reaching implications in understanding how the immune response is controlled.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20354143 PMCID: PMC2909277 DOI: 10.1096/fj.09-144295
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191